Sectoral Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,616
Closed -$1.4M 78
2025
Q4
$1.4M Sell
7,616
-1,759
-19% -$309K 1.12% 26
2025
Q3
$1.44M Buy
9,375
+55
+0.6% +$8.32K 0.89% 40
2025
Q2
$1.3M Sell
9,320
-75
-0.8% -$10.5K 0.86% 41
2025
Q1
$1.38M Buy
9,395
+2,070
+28% +$299K 1.07% 25
2024
Q4
$960K Sell
7,325
-3,345
-31% -$468K 0.64% 44
2024
Q3
$2.47M Sell
10,670
-155
-1% -$25K 1.46% 19
2024
Q2
$1.69M Sell
10,825
-1,390
-11% -$209K 0.69% 43
2024
Q1
$1.66M Sell
12,215
-850
-7% -$113K 0.65% 47
2023
Q4
$1.76M Buy
13,065
+655
+5% +$85.1K 0.76% 53
2023
Q3
$1.68M Buy
12,410
+1,797
+17% +$245K 0.33% 90
2023
Q2
$1.52M Buy
10,613
+608
+6% +$89.5K 0.25% 98
2023
Q1
$1.39M Hold
10,005
0.27% 87
2022
Q4
$1.36M Buy
10,005
+250
+3% +$31.4K 0.26% 86
2022
Q3
$1.07M Buy
9,755
+1,550
+19% +$197K 0.21% 84
2022
Q2
$1.08M Buy
+8,205
New +$1.08M 0.22% 86
2020
Q3
Sell
-70,900
Closed -$7.5M 100
2020
Q2
$7.5M Sell
70,900
-12,000
-14% -$1.24M 0.69% 55
2020
Q1
$7.41M Buy
82,900
+4,000
+5% +$377K 1.42% 30
2019
Q4
$7.87M Buy
+78,900
New +$7.43M 1.17% 35
2018
Q4
Sell
-3,550
Closed -$281K 109
2018
Q3
$281K Buy
+3,550
New +$269K 0.03% 115

Other funds holding AZN

Sectoral Asset Management's AZN Position: Q1 2026 in Review

Sectoral Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 7,616 shares — an estimated $1.4M sold.

Sectoral Asset Management first reported a position in AZN in Q3 2018 and held it in 19 quarters. The position peaked at $7.87M in Q4 2019. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Sectoral Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Sectoral Asset Management sold 7,616 AstraZeneca shares in Q1 2026, an estimated $1.4M.
  • Sectoral Asset Management first reported a position in AstraZeneca in Q3 2018 and held it in 19 quarters.
  • Sectoral Asset Management's AstraZeneca position peaked at $7.87M in Q4 2019.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.